The influence of natural menopause on postprandial lipemia in heterozygotes for familial hypercholesterolemia

Journal of Women's Health

Volumn 13, Issue 10, 2004, Pages 1119-1126

  Kolovou, Genovefa D ^a   Anagnostopoulou, Katherine K ^a   Pilatis, Nektarios D ^a   Giannopoulou, Mirto ^a   Hoursalas, Ioannis S ^a   Pavlidis, Antonis N ^a   Adamopoulou, Evdokia ^a   Valaora, Alexandra I ^a   Mikhailidis, Dimitri P ^b   Cokkinos, Dennis V ^a,c  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; LIPID; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY FAT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL HYPERCHOLESTEROLEMIA; FAT INTAKE; FEMALE; GREECE; HETEROZYGOTE; HUMAN; HYPERLIPIDEMIA; LIPID DIET; MENOPAUSE; POSTMENOPAUSE; POSTPRANDIAL STATE; PREDICTION; PREMENOPAUSE; PRIORITY JOURNAL; STANDARDIZATION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 19944430716     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2004.13.1119     Document Type: Article

References (47)

1. Castelo-Branco C, Blumel JE, Roncagliolo ME, et al. Age, menopause and hormone replacement therapy influences on cardiovascular risk factors in a cohort of middle-aged Chilean women. Maturitas 2003;45: 205.
2. Brophy DF, Crouch MA, Ruffin DM, Wazny LD, McKenney JM. Pharmacotherapy of dyslipidemia in postmenopausal women: Weighing the evidence. J Wom Health Gender Based Med 1999;8:901.
3. Torng PL, Su TC, Sung FC, et al. Effects of menopause on intraindividual changes in serum lipids, blood pressure, and body weight - The Chin-Shan Community Cardiovascular Cohort study. Atherosclerosis 2002;161:409.
4. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003;88: 2404.
5. Wiegman A, Rodenburg J, de Jongh S, et al. Family history and cardiovascular risk in familial hypercholesterolemia. Data in more than 1000 children. Circulation 2003;107:1473.
6. Mercuro G, Zoncu S, Dragoni F. Gender differences in cardiovascular risk factors. Ital Heart J 2003;4:363.
7. Farmer JA, Gotto AM Jr. The Heart Protection Study: Expanding the boundaries for high-risk coronary disease prevention. Am J Cardiol 2003;92:3i.
8. Packard CJ, Saito Y. Non-HDL cholesterol as a measure of atherosclerotic risk. J Atheroscler Thromb 2004;11:6.
9. Jones PH. Clinical diagnosis of lipid disorders. Clin Cornerstone 1998;1:15.
10. Groot PH, van Stiphout WA, Krauss XH, et al. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb 1991;11:653.
11. Patsch JR, Miesenbock G, Hopferwieser T, et al. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb 1992;12:1336.
12. Orth M, Dierkes J, Luley C. Chylomicron remnant concentrations in patients with coronary artery disease. Clin Chem Lab Med 2003;41:652.
13. Meyer E, Westerveld HT, de Ruyter-Meijstek FC, et al. Abnormal postprandial apolipoprotein B-48 and triglyceride responses in normolipidemic women with greater than 70% stenotic coronary artery disease: A case-control study. Atherosclerosis 1996;124: 221.
14. Chapman JM, Guerin M, Bruckert E. Role of anomalies of low-density lipoproteins (LDL) in atherogenicity. Bull Acad Natl Med 2001;185:35.
15. Lemieux I, Couillard C, Pascot A, et al. The small, dease LDL phenotype as a correlate of postprandial lipemia in men. Atherosclerosis 2000;153:423.
16. Watts GF. Postprandial lipaemia in familial hypercholesterolaemia: Clinical and metabolic significance. Atherosclerosis 2000;148:426.
17. Yu KC, Cooper AD. Postprandial lipoproteins and atherosclerosis. Front Biosci 2001;6:D332.
18. Kolovou G, Daskalova D, Anagnostopoulou K, et al. Postprandial hypertriglyceridaemia in patients with Tangier disease. J Clin Pathol 2003;56:937.
19. Kolovou GD, Daskalova DCh, Iraklianou SA, et al. Postprandial lipemia in hypertension. J Am Coll Nutr 2003;22:80.
20. Kolovou G, Adamopoulou E, Kafaltis N, Hatzaki A, Valaora A. Essential hypertension is associated with an abnormal TG response after fat loading. Circulation 1998;98 (Suppl 1):860.
21. Marks D, Thorogood M, Neil HA, Humphries SE. A review on the diagnosis, natural history, and treatmet of familial hypercholesterolaemia. Atherosclerosis 2003;168:1.
22. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adults Treatment Panel III). JAMA 2001;285:2486.
23. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of the low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentifuge. Clin Chem 1972;18:499.
24. Welty FK. Preventing clinically evident coronary heart disease in the postmenopausal woman. Menopause 2004;11:484.
25. Stevenson JC, Crook D, Godsland IF. Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis 1993;98:83.
26. Lindquist O, Bengtsson C. Serum lipids, arterial blood pressure and body weight in relation to the menopause: Results from a population study of women in Goteborg, Sweden. Scand J Clin Lab Invest 1980;40: 629.
27. Wakatsuki A, Okatani Y, Ikenoue N. Effects of combination therapy with estrogen plus simvastatin on lipoprotein metabolism in postmenopausal women with type IIa hypercholesterolemia. Atherosclerosis 2000;150:103.
28. Mercuro G, Zoncu S, Saiu F, Sarais C, Rosano G. Effect of atorvastatin on endothelium-dependent vasodilation in postmenopausal women with average serum cholesterol levels. Am J Cardiol 2002;90:747.
29. Nowinski K, Pripp U, Carlstrom K, Landgren BM, Schenk-Gustafsson K, Bergfeldt L. Repolarization measures and their relation to sex hormones in postmenopausal women with cardiovascular disease receiving hormone replacement therapy. Am J Cardiol 2002;90:1050.
30. Gami AS, Wright RS, Ballman KV, Kopecky SL, Hayes SN. Hormone replacement therapy and risk of acute myocardial infarction in postmenopausal women with diabetes mellitus. Am J Cardiol 2003;91:1275.
31. van Beek AP, de Ruijter-Heijstek FC, Erkelens DW, de Bruin TW. Menopause is associated with reduced protection from postprandial lipemia. Arterioscler Thromb Vasc Biol 1999;19:2737.
32. Jensen J, Nilas L, Christiansen C. Influence of menopause on serum lipids and lipoproteins. Maturitas 1990;12:321.
33. Couillard C, Bergeron N, Prud'homme D, et al. Gender difference in postprandial lipemia: Importance of visceral adipose tissue accumulation. Arterioscler Thromb Vasc Biol 1999;19:2448.
34. Kovar J, Poledne R. Sex differences in the response of postprandial lipemia to a change from a low-fat low-cholesterol diet to a high-fat high-cholesterol diet. Physiol Res 2000;49:233.
35. Field PA, Gibbons GF. Decreased hepatic expression of the low-density lipoprotein (LDL) receptor and LDL receptor-related protein in aging rats is associated with delayed clearance of chylomicrons from the circulation. Metabolism 2000;49:492.
36. Mortimer BC, Beveridge DJ, Phan CT, Lutton C, Redgrave TG. The diurnal rhythms of cholesterol metabolism and plasma clearance of model chylomicrons: Comparison of normal and genetically hypercholesterolemic rats (RICO). Comp Biochem Physiol A Mol Integr Physiol 1998;120:671.
37. Kowal RC, Herz J, Weisgraber KH, Mahley RW, Brown MS, Goldstein JL. Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein. J Biol Chem 1990;265:10771.
38. Aronow WS. Pharmacologic therapy of lipid disorders in the elderly. Am J Geriatr Cardiol 2002;11:247.
39. LaRosa JC. Triglycerides and coronary risk in women and the elderly. Arch Intern Med 1997;157:961.
40. Kannel WB. Coronary heart disease risk factors in the elderly. Am J Geriatr Cardiol 2002;11:101.
41. Bergeron N, Havel RJ. Assessment of postprandial lipemia: Nutritional influences. Curr Opin Lipidol 1997;8:43.
42. Kolovou GD, Anagnostopoulou KK, Pilatis ND, et al. Heterozygote men with familial hypercholesterolaemia (FH) may have an abnormal triglyceride response postprandially. Evidence for another predictor of vascular risk in FH. Int J Clin Pract 2004 In press.
43. Kolovou GD, Anagnostopoulou KK, Pilatis N, et al. Low fasting low high-density lipoprotein and postprandial lipemia. Lipids Health Dis 2004;3:18.
44. Couillard C, Bergeron N, Bergeron J, et al. Metabolic heterogeneity underlying postprandial lipemia among men with low fasting high-density lipoprotein cholesterol concentrations. J Clin Endocrinol Metab 2000;85:4575.
45. Cohen JC, Stray-Gundersen J, Grundy SM. Dissociation between postprandial lipemia and high-density lipoprotein cholesterol concentrations in endurance-trained men. Arterioscler Thromb 1991;11:838.
46. Kolovou G, Daskalova D, Mikhailidis DP. Apolipoprotein E polymorphism and atherosclerosis. Angiology 2003;54:59.
47. Sijbrands EJ, Westendorp RG, Paola Lombardi M, et al. Additional risk factors influence excess mortality in heterozygous familial hypercholesterolaemia. Atherosclerosis 2000;149:421.